A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients

Completed · Phase 4

Conditions studied: Schizophrenia

In brief

The purpose of this study is to compare the efficacy and safety of ziprasidone and aripiprazole in hospitalized patients with schizophrenia or schizoaffective disorder

Key facts

Study ID

NCT00634348

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

256

Starts

2004-04-01

Expected to finish

2005-03-01

Last updated by the study team

2021-02-21

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hospitalized patients with schizophrenia or schizoaffective disorder
• At least a 6th grade reading level
• Males or females, between 18 and 70 years of age at the time of consent
• Subjects must have been hospitalized for no more than 14 consecutive days immediately prior to screening

You may not qualify if…

• Psychiatric disorder other than schizophrenia or schizoaffective disorder
• History of arrhythmia, heart attack, or heart failure

Where it is running

• Pfizer Investigational Site — Anaheim, California, United States
• Pfizer Investigational Site — Cerritos, California, United States
• Pfizer Investigational Site — Culver City, California, United States
• Pfizer Investigational Site — Garden Grove, California, United States
• Pfizer Investigational Site — Glendale, California, United States
• Pfizer Investigational Site — La Mesa, California, United States
• Pfizer Investigational Site — Newport Beach, California, United States
• Pfizer Investigational Site — Paramount, California, United States
• Pfizer Investigational Site — Riverside, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Torrance, California, United States
• Pfizer Investigational Site — Upland, California, United States
• Pfizer Investigational Site — Washington D.C., District of Columbia, United States
• Pfizer Investigational Site — Hialeah, Florida, United States
• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — Rockville, Maryland, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — Clementon, New Jersey, United States
• Pfizer Investigational Site — Princeton, New Jersey, United States
• Pfizer Investigational Site — Willingboro, New Jersey, United States
• Pfizer Investigational Site — Woodlane, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.